However, a study where TAMs were examined in the low-grade dysplasia (LGD)–high-grade dysplasia (HGD)–invasive carcinoma pathway has shown a rise in CD68+ cells in adenomas, which was followed by a decrease in the invasive carcinoma stage [54]. The gene discussed is CD68; the disease is adenoma.